SCHEMBL1081071

SCHEMBL1081071

C[C@@H]1CCN(C(=O)O)[C@@H]1C(=O)O

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.31
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1025789 1.00 ATM (0.31) ATMMAPT
SCHEMBL13677158 0.85 ATM (0.41) ATM
SCHEMBL27156699 0.85 ATM (0.41) ATM
SCHEMBL19084014 0.85 ATM (0.41) ATM
SCHEMBL19083748 0.80 PIK3CD (0.40) MAPT
SCHEMBL19083750 0.80 TSHR (0.37) MAPT
SCHEMBL19075601 0.80 RIPK1 (0.46)
SCHEMBL627415 0.77 HSD17B10 (0.47)
Ethane SCHEMBL4767713 0.77 HSD17B10 (0.47)
SCHEMBL6078598 0.77 HSD17B10 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448946-A1 2-CARBOXAMIDE CYCLOAMINO UREAS USEFUL AS PI3K INHIBITORS Novartis AG (CH) 2012-05-09 EP disclosed
WO-2011000855-A1 2-CARBOXAMIDE CYCLOAMINO UREAS USEFUL AS PI3K INHIBITORS NOVARTIS AG (CH) 2011-01-06 WO disclosed